NCT04628494: An ongoing trial by Genmab
This trial is ongoing. It must report results 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04628494 |
|---|---|
| Title | A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 13, 2021 |
| Completion date | Oct. 13, 2025 |
| Required reporting date | Oct. 13, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |